摘要
目的分析脑苷肌肽治疗新生儿缺氧缺血性脑病的临床效果。方法将68例研究对象随机分为对照组与观察组,对照组给予常规治疗,观察组在常规治疗基础上联合脑苷肌肽治疗。结果观察组总有效率高于对照组(P<0.05);治疗前,观察组患儿NBNA评分与对照组比较,差异无统计学意义(P>0.05);治疗后,观察组患儿NBNA评分高于对照组,差异有统计学意义(P<0.05)。结论脑苷肌肽治疗新生儿缺氧缺血性脑病的临床效果较好。
Objective To analyze the clinical effect of GM1 on neonatal hypoxic ischemic encephalopathy. Methods 68 subjects were randomly divided into for the control group and the observation group, the control group was given conventional treatment, observation group in the conventional treatment based on the treatment of the cerebroside karnosin combined. Results The total effective rate in the observation group was significantly higher than that in the control group （P〈0.05）, the NBNA score in the observation group was significantly higher than that in the control group （P〉0.05）, the NBNA score in the observation group was significantly higher than that in the control group （P〈0.05）. Conclusion The GMI treatment of clinical effect of neonatal hypoxic ischemic encephalopathy.
出处
《中国继续医学教育》
2015年第33期170-171,共2页
China Continuing Medical Education
